CDK2 and cancer: Unlike the outcomes of CDK2-inhibited aneuploid cancer cells, primary cultures of human alveolar epithelial cells were resistant to the growth-inhibitory or proapoptotic effects of this treatment, as displayed in Figure 6f,g.